Skip to main content

and
  1. No Access

    Article

    Incidence and risk of hypertension with pazopanib in patients with cancer: a meta-analysis

    To gain a better understanding of the overall incidence and risk of hypertension in cancer patients who receive pazopanib and to compare the differences in incidence among sorafenib, sunitinib, and pazopanib.

    Wei-**ang Qi, Feng Lin, Yuan-jue Sun, Li-Na Tang in Cancer Chemotherapy and Pharmacology (2013)

  2. No Access

    Article

    Down-regulation of ribosomal protein L7A in human osteosarcoma

    To explore the expression of ribosomal protein L7A (RPL7A) in osteosarcoma and its correlation with clinical features.

    Shui-er Zheng, Yang Yao, Yang Dong, Feng Lin in Journal of Cancer Research and Clinical On… (2009)